RxSight Inc (RXST)
61.68
+2.05
(+3.44%)
USD |
NASDAQ |
May 03, 16:00
61.78
+0.10
(+0.15%)
After-Hours: 20:00
RxSight Cash from Investing (TTM): -22.13M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -22.13M |
September 30, 2023 | -16.29M |
June 30, 2023 | -33.00M |
March 31, 2023 | -23.27M |
December 31, 2022 | 39.95M |
September 30, 2022 | -5.801M |
June 30, 2022 | -86.60M |
Date | Value |
---|---|
March 31, 2022 | -81.55M |
December 31, 2021 | -81.91M |
September 30, 2021 | -61.08M |
June 30, 2021 | 25.57M |
March 31, 2021 | 5.869M |
December 31, 2020 | 15.59M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-86.60M
Minimum
Jun 2022
39.95M
Maximum
Dec 2022
-24.97M
Average
-22.13M
Median
Dec 2023
Cash from Investing (TTM) Benchmarks
Abbott Laboratories | -3.133B |
Alphatec Holdings Inc | -141.98M |
AtriCure Inc | 2.648M |
Intuitive Surgical Inc | -1.062B |
iRhythm Technologies Inc | -1.209M |